Infectious diseases
Expertise for rapid diagnosis
Through our integration with Mayo Clinic, Mayo Clinic Laboratories leads the industry in turning test results into clinical answers. Informed by our experience in both common and extremely rare infectious diseases, we have developed a vast test menu of over 400 tests to detect and diagnose infectious diseases. We’re continually innovating to find better ways to provide answers, giving you and your patients access to the most cutting-edge testing and technologies.
Highlights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, speaks with William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, about Ebola, hantavirus and takeaways from a recent healthcare conference. Later, she welcomes Elli Theel, Ph.D., a microbiologist in Mayo Clinic’s Department of Laboratory Medicine and Pathology, to explore vector-borne diseases.
Register now – Aug. 11, 2026 Four case studies to explore key diagnostic considerations when Lyme testing is negative, highlight the role of geographic exposure history, and demonstrate the utility of multiplex testing panels
Discover how efficient, evidence-based serologic testing algorithms can accelerate Coccidioides infection diagnosis, simplify laboratory workflow, and provide practical benefits for laboratorians and healthcare professionals.
The Mayo Clinic Parasitology Workshop offers an immersive learning experience focused on practical skills for parasite identification. This two-day program combines expert-led presentations with hands-on laboratory sessions to help participants apply diagnostic techniques with confidence. Reserve your spot today.
Viral and pharmacogenomic testing help clinicians detect infection early, tailor immunosuppression, and improve long-term outcomes for organ transplant recipients.
Registration is now open for the 2026 Mayo Clinic Parasitology Workshop. This interactive two-day program is designed to enhance your diagnostic skills through expert-led lectures and hands-on laboratory sessions.
Explore the intersection of medical science and personal well-being. In this informative and engaging presentation, Bobbi Pritt, M.D., draws on her expertise in clinical microbiology and parasitology to illuminate how the study of parasites offers valuable lessons for health, resilience, and lifelong growth.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent news updates and key advancements shaping the industry in 2025.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and the first reported death from alpha-gal syndrome. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer and medical director of BioPharma Diagnostics, to explore how biopharma diagnostics advance research and development.
November 3, 2025 - In this video, Dr. Andrew McKeon describes how the field of autoimmune neurology testing has changed with the explosion of antibody discovery and discusses the importance of a patient-first, phenotype-based approach.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories and Trish Simner, Ph.D., a clinical microbiologist at Mayo Clinic to discuss recent news about Protecting Access to Medicare Act (PAMA) reform followed by an in-depth conversation about metagenomics.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories. Together, they discuss recent news about virus activity and explore the value of collaboration in shaping innovative diagnostic strategies.